RedShiftBio

Next Generation in Protein Characterization

RedShiftBio’s AQS³pro Wins a ‘The Analytical Scientist Innovation Award’ (TASIA) 2018

TASIA showcases the technologies driving the advancement of measurement science.

The Next Generation in Protein Characterization

The AQS³pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS³pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS³delta Analytical Software package, it streamlines and simplifies 5 key measurements:

Aggregation | Quantitation | Stability | Structure | Similarity

See change in your protein, in your workflow, and in your efficiency.

Visit the product page to learn more.

Watch our latest webinar replay

DOWNLOAD

Load samples and walk away.

The widest concentration range to characterize biotherapeutics.

Generate precise, high sensitivity data.

Analyze and understand protein behavior.

Latest News

Photonics Media publishes article on Technological Synergies Move Spectroscopy Out of the Lab

RedShiftBio Expands Team to Support Demand for AQS³™pro

RedShiftBio’s AQS³™pro : Finalist in The Prism Awards 2019

RedShiftBio Expands Team to Support Launch of FlagShip AQS³™pro System for Protein Characterization.

Instrument Business Outlook interviews RedShiftBio CCO Jeff Zonderman on the launch of the AQS³pro.

Spectroscopy Europe highlights the launch of the AQS³pro.

RedShiftBio Launches AQS³pro Protein Characterization System.

Where you can meet us next

Biotherapeutics Analytical Summit, Mar 4-8 2019, Alexandria, VA

Pittcon 2019, Mar 17-21, Philadelphia

HOS 2019, Apr 8 - 10 2019, San Mateo, CA

PEGS 2019 Apr 8-12, Boston, MA

2019 Colorado Protein Stability Conference, July 29 - Aug 1, Colorado

PEGS Europe, Nov 18-22, Lisbon

RedShiftBio™

RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com

RedShift™, RedShiftBio™, See Change™, and AQS³™ are trademarks of RedShift BioAnalytics, Inc.

Class 1 Laser Device Complies with 21 CFR Chapter 1, Subchapter J, Part 1040.10